Bio-Techne CorpHere is the public summary page for Bio-Techne Corp. Please login to see the complete information for Bio-Techne Corp including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Bio-Techne Corp stacks up relative to its peers. |
| Darwin Score | -7 |
| Ticker | TECH |
| Latest Price | 51.79 USD as of close on 16-Jul-2025 |
| 3 Month price range | 46.66 to 54.41 USD |
| Market Capitalisation | 8.25Bn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Life Sciences Tools & Services |
| Sub-Industry | Life Sciences Tools & Services |
| Description | Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota. See More ... |
| Company URL | https://www.bio-techne.com |
| See Darwins Full Analysis for Bio-Techne Corp |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Bio-Techne Corp. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +4 |
| Sentiment | News and Candle Patterns. | +1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +4 |
| Flow | Institutional, Fund and Insider buying and selling. | -1 |
| Models | Forecast models. | -15 |
Alerts
There are 7 live alerts for Bio-Techne Corp.
- Oversold - The 5 day RSI is +23.4. (Positive)
- Divergence: Px Down & OBV Up last 65 days. This alert has occurred 155 times over the last last year. The average forward returns are -0.2% over 5 days, -0.4% over 10 days, -0.7% over 15 days and -1.5% over 20 days. (Positive)
- Divergence: Px Down & OBV Up last 10 days. This alert has occurred 142 times over the last last year. The average forward returns are -0.3% over 5 days, -0.4% over 10 days, -0.4% over 15 days and -1.4% over 20 days. (Positive)
- 5d RSI Oversold. This alert has occurred 74 times over the last last year. The average forward returns are 0.5% over 5 days, -0.1% over 10 days, -0.2% over 15 days and -1.1% over 20 days. (Negative)
- Divergence: Px Up & 30d RSI Down last 20 days. This alert has occurred 7 times over the last last year. The average forward returns are -3.4% over 5 days, -6.7% over 10 days, -7.4% over 15 days and -4.8% over 20 days. (Negative)
- Divergence: Px Up & 15d RSI Down last 20 days. This alert has occurred 11 times over the last last year. The average forward returns are -2.5% over 5 days, -4.9% over 10 days, -5.8% over 15 days and -2.9% over 20 days. (Negative)
- Cross Over (Down): 20dma . This alert has occurred 13 times over the last last year. The average forward returns are -0.3% over 5 days, -0.9% over 10 days, -2.5% over 15 days and -1.5% over 20 days. (Negative)
Peer Comparison
There are 7 peers of Bio-Techne Corp.
| Asset Name | Industry Group | Asset Score |
|---|---|---|
| Azenta Inc (AZTA) | Life Sciences Tools & Services | +4 |
| Illumina Inc (ILMN) | Life Sciences Tools & Services | +9 |
| Medpace Holdings Inc (MEDP) | Life Sciences Tools & Services | +32 |
| Mesa Laboratories Inc (MLAB) | Life Sciences Tools & Services | -3 |
| Repligen Corp (RGEN) | Life Sciences Tools & Services | -4 |
| Sotera Health Co (SHC) | Life Sciences Tools & Services | -13 |
| Tempus AI Inc (TEM) | Life Sciences Tools & Services | -7 |
Share 
